Cargando…
Advanced Malignant Melanoma: Immunologic and Multimodal Therapeutic Strategies
Immunologic treatment strategies are established in malignant melanoma treatment, mainly focusing on Interleukin-2 in advanced disease and interferon alpha in the adjuvant situation. In advanced disease, therapies with IL-2, interferon and different chemotherapeutic agents were not associated with b...
Autores principales: | Halama, Niels, Zoernig, Inka, Jaeger, Dirk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836142/ https://www.ncbi.nlm.nih.gov/pubmed/20224761 http://dx.doi.org/10.1155/2010/689893 |
Ejemplares similares
-
The local immunological microenvironment in colorectal cancer as a prognostic factor for treatment decisions in the clinic: The way ahead
por: Halama, Niels, et al.
Publicado: (2012) -
Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification
por: Halama, Niels, et al.
Publicado: (2009) -
Predictive Immunological Markers in Oncology
por: Jäger, Dirk, et al.
Publicado: (2012) -
Sequence mutations of the substrate binding pocket of stem cell factor and multidrug resistance protein ABCG2 in renal cell cancer: A possible link to treatment resistance
por: ZOERNIG, INKA, et al.
Publicado: (2013) -
Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival
por: Berthel, Anna, et al.
Publicado: (2017)